Kahn Lab

Drolet, M; Bénard, É; Pérez, N; Brisson, M; Ali, H; Boily, M; Baldo, V; Brassard, P; Brotherton, JM L; Callander, D; et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet. 2019; 394:497-509.

Covert, C; Ding, L; Brown, D; Franco, EL; Bernstein, DI; Kahn, JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Human Vaccines and Immunotherapeutics. 2019; 15:1962-1969.

Spinner, C; Ding, L; Bernstein, DI; Brown, DR; Franco, EL; Covert, C; Kahn, JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. 2019; 143:e20181902-e20181902.

Hackworth, J; Steel, S; Cooksey, E; DePalma, M; Kahn, JA. Faculty Members' Self-Awareness, Leadership Confidence, and Leadership Skills Improve after an Evidence-Based Leadership Training Program. The Journal of Pediatrics. 2018; 199:4-6.e2.

Chandler, E; Ding, L; Gorbach, P; Franco, EL; Brown, DA; Widdice, LE; Bernstein, DI; Kahn, JA. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction. Journal of Adolescent Health. 2018; 63:43-49.

Kahn, JA; Lee, J; Belzer, M; Palefsky, JM; Consortium, AI D S M; HIV, AM T N. HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination. AIDS and Behavior. 2018; 22:1826-1834.

Saccucci, M; Franco, EL; Ding, L; Bernstein, DI; Brown, D; Kahn, JA. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection. Sexually Transmitted Diseases. 2018; 45:260-265.

Rosen, BL; Bishop, JM; McDonald, SL; Kahn, JA; Kreps, GL. Quality of Web-Based Educational Interventions for Clinicians on Human Papillomavirus Vaccine: Content and Usability Assessment. JMIR Cancer. 2018; 4:e3-e3.

Mullins, TL K; Rosenthal, SL; Zimet, GD; Ding, L; Morrow, C; Huang, B; Kahn, JA. Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination. Journal of Adolescent Health. 2018; 62:164-169.

Kahn, JA; Widdice, LE; Ding, L; Huang, B; Brown, DR; Franco, EL; Bernstein, DI. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Clinical Infectious Diseases. 2016; 63:1281-1287.

Kahn, J; Trotman, G; Vash-Margita, A; Feldman, S. Human Papillomavirus Infection and Cervical Cancer Screening and Prevention in Adolescents. In: Emans SJ; Laufer MR, Ed. Pediatric and Adolescent Gynecology. Philadelphia, PA: Lippincott-Raven; 2019.

Widdice, LE; Bernstein, DI; Franco, EL; Ding, L; Brown, DR; Ermel, AC; Higgins, L; Kahn, JA. Decline in vaccine-type human papillomavirus prevalence in young men from a Midwest metropolitan area of the United States over the six years after vaccine introduction. Vaccine. 2019; 37:6832-6841.

Drolet, M; Bénard, É; Pérez, N; Brisson, M; Ali, H; Boily, M; Baldo, V; Brassard, P; Brotherton, JM L; Callander, D; et al. Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis. The Lancet. 2019; 394:497-509.

Covert, C; Ding, L; Brown, D; Franco, EL; Bernstein, DI; Kahn, JA. Evidence for cross-protection but not type-replacement over the 11 years after human papillomavirus vaccine introduction. Human Vaccines and Immunotherapeutics. 2019; 15:1962-1969.

Thomas, R; Dillard, M; Xu, J; Zimet, GD; Kahn, JA. Risk perceptions after human papillomavirus vaccination are not subsequently associated with riskier behaviors or sexually transmitted infections in HIV-infected young women. Human Vaccines and Immunotherapeutics. 2019; 15:1732-1736.

Kahn, JA; Belzer, M; Chi, X; Lee, J; Gaur, AH; Mayer, K; Martinez, J; Futterman, DC; Stier, EA; Paul, ME; et al. Pre-vaccination prevalence of anogenital and oral human papillomavirus in young HIV-infected men who have sex with men. Papillomavirus Research. 2019; 7:52-61.

Mullins, TL K; Idoine, CR; Zimet, GD; Kahn, JA. Primary Care Physician Attitudes and Intentions Toward the Use of HIV Pre-exposure Prophylaxis in Adolescents in One Metropolitan Region. Journal of Adolescent Health. 2019; 64:581-588.

Charlton, BM; Kahn, JA; Sarda, V; Katz-Wise, SL; Spiegelman, D; Missmer, SA; Austin, SB. Maternal Factors and Sexual Orientation-Related Disparities in Cervical Cancer Prevention. Women's Health Issues. 2019; 29:238-244.

Spinner, C; Ding, L; Bernstein, DI; Brown, DR; Franco, EL; Covert, C; Kahn, JA. Human Papillomavirus Vaccine Effectiveness and Herd Protection in Young Women. Pediatrics. 2019; 143:e20181902-e20181902.

Morrow, C; Ding, L; Gorbach, P; Chandler, E; Crumpton, M; Kahn, JA. RATES AND PREDICTORS OF HUMAN PAPILLOMAVIRUS VACCINATION AMONG YOUNG MEN RECRUITED FROM URBAN CLINICAL AND COMMUNITY SETTINGS. Journal of Men's Health. 2019; 15:E30-E44.

Tatar, O; Thompson, E; Naz, A; Perez, S; Shapiro, GK; Wade, K; Zimet, G; Gilca, V; Janda, M; Kahn, J; et al. Factors associated with human papillomavirus (HPV) test acceptability in primary screening for cervical cancer: A mixed methods research synthesis. Preventive Medicine. 2018; 116:40-50.

Kasting, ML; Christy, SM; Sutton, SK; Lake, P; Malo, TL; Roetzheim, RG; Schechtman, T; Zimet, GD; Walkosz, BJ; Salmon, D; et al. Florida physicians' reported use of AFIX-based strategies for human papillomavirus vaccination. Preventive Medicine. 2018; 116:143-149.

Hackworth, J; Steel, S; Cooksey, E; DePalma, M; Kahn, JA. Faculty Members' Self-Awareness, Leadership Confidence, and Leadership Skills Improve after an Evidence-Based Leadership Training Program. The Journal of Pediatrics. 2018; 199:4-6.e2.

Thomas, R; Higgins, L; Ding, L; Widdice, LE; Chandler, E; Kahn, JA. Factors Associated With HPV Vaccine Initiation, Vaccine Completion, and Accuracy of Self-Reported Vaccination Status Among 13-to 26-Year-Old Men. American Journal of Men's Health. 2018; 12:819-827.

Chandler, E; Ding, L; Gorbach, P; Franco, EL; Brown, DA; Widdice, LE; Bernstein, DI; Kahn, JA. Epidemiology of Any and Vaccine-Type Anogenital Human Papillomavirus Among 13-26-Year-Old Young Men After HPV Vaccine Introduction. Journal of Adolescent Health. 2018; 63:43-49.

Kahn, JA; Lee, J; Belzer, M; Palefsky, JM; Consortium, AI D S M; HIV, AM T N. HIV-Infected Young Men Demonstrate Appropriate Risk Perceptions and Beliefs about Safer Sexual Behaviors after Human Papillomavirus Vaccination. AIDS and Behavior. 2018; 22:1826-1834.

Smith, C; Ding, L; Gorbach, PM; Franco, EL; Kahn, JA. Who's Not Protected in the Herd? Factors Associated with Vaccine-Type HPV in Unvaccinated Women. Journal of Pediatric and Adolescent Gynecology. 2018; 31:89-93.

Morrow, C; Thomas, R; Ding, L; Kahn, JA. Prevalence of potential sexual abuse in adolescents and young adults and feasibility of an assessment and management plan used in three research projects. Research in Nursing and Health. 2018; 41:166-172.

Saccucci, M; Franco, EL; Ding, L; Bernstein, DI; Brown, D; Kahn, JA. Non-Vaccine-Type Human Papillomavirus Prevalence After Vaccine Introduction: No Evidence for Type Replacement but Evidence for Cross-Protection. Sexually Transmitted Diseases. 2018; 45:260-265.

Widdice, LE; Hoagland, R; Callahan, ST; Kahn, JA; Harrison, CJ; Pahud, BA; Frey, SE; Berry, AA; Kotloff, KL; Edwards, KM; et al. Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series. Vaccine. 2018; 36:1491-1499.

Rosen, BL; Shepard, A; Kahn, JA. US Health Care Clinicians' Knowledge, Attitudes, and Practices Regarding Human Papillomavirus Vaccination: A Qualitative Systematic Review. Academic Pediatrics. 2018; 18:S53-S65.

Rosen, BL; Bishop, JM; McDonald, SL; Kahn, JA; Kreps, GL. Quality of Web-Based Educational Interventions for Clinicians on Human Papillomavirus Vaccine: Content and Usability Assessment. JMIR Cancer. 2018; 4:e3-e3.

Mullins, TL K; Rosenthal, SL; Zimet, GD; Ding, L; Morrow, C; Huang, B; Kahn, JA. Human Papillomavirus Vaccine-Related Risk Perceptions Do Not Predict Sexual Initiation Among Young Women Over 30 Months Following Vaccination. Journal of Adolescent Health. 2018; 62:164-169.

Ben-Harush Negari, S; Kahn, J. Human Papillomavirus. In: Read J; Schleiss M, Ed. Congenital and Neonatal Infections. Oxford, England: Oxford University Press; 2018.

Ding, L; Widdice, LE; Kahn, JA. Differences between vaccinated and unvaccinated women explain increase in non-vaccine-type human papillomavirus in unvaccinated women after vaccine introduction. Vaccine. 2017; 35:7217-7221.

Reed, JL; Punches, BE; Taylor, RG; Macaluso, M; Alessandrini, EA; Kahn, JA. A Qualitative Analysis of Adolescent and Caregiver Acceptability of Universally Offered Gonorrhea and Chlamydia Screening in the Pediatric Emergency Department. Annals of Emergency Medicine. 2017; 70:787-796.e2.

Mullins, TL K; Zimet, G; Lally, M; Xu, J; Thornton, S; Kahn, JA; HIV, AM T N. HIV Care Providers' Intentions to Prescribe and Actual Prescription of Pre-Exposure Prophylaxis to At-Risk Adolescents and Adults. AIDS patient care. 2017; 31:504-516.

Rosen, BL; Shew, ML; Zimet, GD; Ding, L; Mullins, TL K; Kahn, JA. Human Papillomavirus Vaccine Sources of Information and Adolescents' Knowledge and Perceptions. Global Pediatric Health. 2017; 4:2333794X17743405-2333794X17743405.

Kahn, JA; Xu, J; Kapogiannis, BG; Sleasman, JW. Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay. Journal of Acquired Immune Deficiency Syndromes. 2017; 75:241-245.

Kahn, JA; Widdice, LE; Ding, L; Huang, B; Brown, DR; Franco, EL; Bernstein, DI. Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community. Clinical Infectious Diseases. 2016; 63:1281-1287.

Kahn, JA; Rudy, BJ; Xu, J; Kapogiannis, B; Secord, E; Gillison, M. Prevalence and Risk Factors for Oral DNA Tumor Viruses in HIV-Infected Youth. Journal of Medical Virology. 2016; 88:1944-1952.

Whittemore, D; Ding, L; Widdice, LE; Brown, DA; Bernstein, DI; Franco, EL; Kahn, JA. Distribution of Vaccine-Type Human Papillomavirus Does Not Differ by Race or Ethnicity Among Unvaccinated Young Women. Journal of Women's Health. 2016; 25:1153-1158.

Vadaparampil, ST; Malo, TL; Sutton, SK; Ali, KN; Kahn, JA; Casler, A; Salmon, D; Walkosz, B; Roetzheim, RG; Zimet, GD; et al. Missing the Target for Routine Human Papillomavirus Vaccination: Consistent and Strong Physician Recommendations Are Lacking for 11-to 12-Year-Old Males. Cancer Epidemiology, Biomarkers and Prevention. 2016; 25:1435-1446.

Mesher, D; Soldan, K; Lehtinen, M; Beddows, S; Brisson, M; Brotherton, JM L; Chow, EP F; Cummings, T; Drolet, M; Fairley, CK; et al. Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes. Emerging Infectious Diseases. 2016; 22:1732-1740.

Mullins, TL K; Zimet, GD; Rosenthal, SL; Morrow, C; Ding, L; Huang, B; Kahn, JA. Human papillomavirus vaccine-related risk perceptions and subsequent sexual behaviors and sexually transmitted infections among vaccinated adolescent women. Vaccine. 2016; 34:4040-4045.

Mullins, TL K; Zimet, G; Lally, M; Kahn, JA; HIV, AM T N. Adolescent Human Immunodeficiency Virus Care Providers' Attitudes Toward the Use of Oral Pre-Exposure Prophylaxis in Youth. AIDS patient care. 2016; 30:339-348.

Kasting, ML; Shapiro, GK; Rosberger, Z; Kahn, JA; Zimet, GD. Tempest in a teapot: A systematic review of HPV vaccination and risk compensation research. Human Vaccines and Immunotherapeutics. 2016; 12:1435-1450.

Higgins, LM; Dirksing, KN; Ding, L; Morrow, CD; Widdice, LA; Kahn, JA. Adolescents' intention and self-efficacy to follow Pap testing recommendations after receiving the HPV vaccine. Human Vaccines and Immunotherapeutics. 2016; 12:1498-1503.

Postenrieder, NR; Reed, JL; Hesse, E; Kahn, JA; Ding, L; Gaydos, CA; Rompalo, A; Widdice, LE. Rapid Antigen Testing for Trichomoniasis in an Emergency Department. Pediatrics. 2016; 137:e20152072-e20152072.

Ben-Harush Negari, ST; Kahn, JA. Human Papillomavirus Infection and Anogenital Warts. In: Neinstein LS; Katzman DK; Callahan ST; Gordon CM; Joffe A; Rickert VI, Ed. Neinstein’s Adolescent and Young Adult Health Care: A Practical Guide. The Netherlands: Wolters Kluwer; 2016.

Grout, RL; Beal, SJ; Kahn, JA; Widdice, LE. Provider-Level Characteristics Associated With Adolescent Varicella, Meningococcal, and Human Papillomavirus Immunization Initiation. Clinical Pediatrics. 2016; 55:44-47.

Reed, J; Huppert, JS; Taylor, RG; Gillespie, GL; Alessandrini, EA; Kahn, JA. The Impact of Post-Visit Emergency Department Follow-Up on Sexually Transmitted Infection Related Return Visits. 2015; 2:1-4.

Mullins, TL K; Widdice, LE; Rosenthal, SL; Zimet, GD; Kahn, JA. Risk perceptions, sexual attitudes, and sexual behavior after HPV vaccination in 11-12 year-old girls. Vaccine. 2015; 33:3907-3912.